Epidaurus Health
Epidaurus Health develops AI-driven software and services to automate and optimize prior authorization workflows for Pharmacy Benefit Managers (PBMs). The company focuses on integrating clinical informatics, data interoperability, and privacy-preserving data exchange to reduce administrative burden, improve clinical decision-making, and accelerate access to medications. Development and commercialization were supported by NSF SBIR funding and pilot engagements with PBMs.
Industries
Nr. of Employees
small (1-50)
Patents
Methods and systems for a synchronized distributed data structure for federated machine learning
US-11552785-B2
View Details
Methods and systems for a synchronized distributed data structure for federated machine learning
US-11552785-B2
View DetailsProducts
Web-based platform for secure automated prior authorization
A commercial platform that automates fulfillment of clinical criteria between payers and providers using privacy-preserving federated architectures and ML to verify evidence provenance and accelerate approvals.
Data pipeline service for EPHI (ETL optimization)
Service designed to optimize extraction, transformation, and loading of clinical records from varied sources to prepare data for automated review and analytics.
Web-based platform for secure automated prior authorization
A commercial platform that automates fulfillment of clinical criteria between payers and providers using privacy-preserving federated architectures and ML to verify evidence provenance and accelerate approvals.
Data pipeline service for EPHI (ETL optimization)
Service designed to optimize extraction, transformation, and loading of clinical records from varied sources to prepare data for automated review and analytics.
Services
Cloud-hosted AI services that automate intake, evidence aggregation, and preliminary review to accelerate prior authorization processing for PBMs.
Curating clinical guidelines and configuring decision criteria to reflect PBM policies and ensure consistent, auditable decision-making.
Services to extract, transform, and normalize electronic personal health information from diverse sources for automated review and analytics.
Cloud-hosted AI services that automate intake, evidence aggregation, and preliminary review to accelerate prior authorization processing for PBMs.
Curating clinical guidelines and configuring decision criteria to reflect PBM policies and ensure consistent, auditable decision-making.
Services to extract, transform, and normalize electronic personal health information from diverse sources for automated review and analytics.
Expertise Areas
- Prior authorization automation
- Clinical decision support for PBMs
- Federated data exchange and provenance
- Clinical data integration and ETL
Key Technologies
- Artificial intelligence / machine learning
- Natural language processing (NLP)
- Federated learning
- Distributed ledger / blockchain-inspired provenance
News & Updates
Article describing limitations of traditional prior authorization workflows and the role of AI in processing entire clinical documents to support clinical decision-making.
Article discussing industry commitments to standardized electronic prior authorization, FHIR APIs, and how AI solutions can help meet those commitments.
Awarded $1M in Phase II SBIR funding from the National Science Foundation to support development of a blockchain/federated platform and AI for optimizing prior authorization.
Spin out as an independent company in 2023, transfer of SBIR award, pilot partnerships, seed funding close, and launch of an ETL-focused service (Parodos) in December 2023.
Announced expansion of product offerings in 2025 (described as additional solutions to support prior authorization workflows).
Article describing limitations of traditional prior authorization workflows and the role of AI in processing entire clinical documents to support clinical decision-making.
Article discussing industry commitments to standardized electronic prior authorization, FHIR APIs, and how AI solutions can help meet those commitments.
Awarded $1M in Phase II SBIR funding from the National Science Foundation to support development of a blockchain/federated platform and AI for optimizing prior authorization.
Spin out as an independent company in 2023, transfer of SBIR award, pilot partnerships, seed funding close, and launch of an ETL-focused service (Parodos) in December 2023.
Announced expansion of product offerings in 2025 (described as additional solutions to support prior authorization workflows).